Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

Kinnate Biopharma Inc. Common Stock (KNTE)

Pharmaceutical Preparations

https://www.kinnate.com

Kinnate Biopharma Inc is a clinical-stage precision oncology company focused on the discovery, design, and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The company's pipeline product candidates are; exarafenib (KIN-2787), which is a Rapidly Accelerated Fibrosarcoma (RAF) inhibitor in development for the treatment of patients with lung cancer, melanoma, and other solid tumors, and KIN-3248, a Fibroblast Growth Factor Receptors (FGFR) inhibitor, designed for the treatment of patients with intrahepatic cholangiocarcinoma (ICC), a cancer of the bile ducts in the liver, and urothelial carcinoma (UC), a cancer of the bladder lining, as well as other solid tumors.

11975 EL CAMINO REAL, STE 101
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/03/2020

Market Cap

124,990,960

Shares Outstanding

47,110,000

Weighted SO

47,112,698

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

AMAM --.--%

SLRN --.--%

WINT --.--%

PALI --.--%

IPSC --.--%

PASG --.--%

FIXX --.--%

GBIO --.--%

STOK --.--%

Beta

1.3400

Last Div

0.0000

Range

1.04-7.185

Chg

-0.0100

Avg Vol

367164

Mkt Cap

124990960

Exch

NASDAQ

Country

US

Phone

858 299 4699

DCF Diff

1.4944

DCF

1.1556

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.5902

P/FV

0.7838

Div Yield %

0.0000

P/E

-1.1257

PEG

-0.1715

Payout

0.0000

Current Ratio

13.1869

Quick Ratio

12.8415

Cash Ratio

4.7518

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

927.8035

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0170

ROA

-0.6390

ROE

-0.5900

ROCE

-0.7486

NI/EBT

0.9848

EBT/EBIT

0.9311

EBIT/Rev

0.0000

Debt Ratio

0.0183

D/E

0.0199

LT Debt/Cap

0.0141

Total Debt/Cap

0.0195

Int Coverage

70.6252

CF/Debt

-31.5096

Equity Multi

1.0896

Rec Turnover

0.0000

Pay Turnover

0.3934

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-2.1230

FCF/Share

-2.1230

Cash/Share

3.2687

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-31.5096

ST Coverage

-112.1558

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.7838

P/B

0.7838

P/S

0.0000

P/E

-1.1257

P/FCF

-1.2494

P/OCF

-1.2483

P/CF

-1.2483

PEG

-0.1715

P/S

0.0000

EV Multiple

-0.5902

P/FV

0.7838

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation